Iványl P, Pavijuková H, Ivasková E
Transplantation. 1976 Dec;22(6):612-8.
Absorption experiments and subsequent retesting on human peripheral lymphocytes were performed with the congenic anti-H2f mouse serum known to give strong cytotoxic reactions with human cells which correlate with the presence of HLA-A2 antigen (mouse serum ASP 223, donor strain B10.M (H-2f), recipients (B10 X A.SW)F1 (H-2b/H-2s) hybrids; antibodies present in the serum anti-H-2.9, 8,37). Depending on the dose of A2-negative cells used for absorption, the serum can be rendered operationally monospecific to HLA-A2. Absorption experiments with lymph node cells of different mouse strains have shown that H-2f.p.w7 haplotypes share the ability to absorb completely the antihuman activity with about 15 X 10(6) cells. Consequently, the antihuman activity is not attributable to the presence of the anti-H-2.9 private specificity in the serum. H-2d.k.r haplotypes have weak absorbing capacity, because 500 X 10(6) lymph node cells are needed to absorb 70% of the antihuman cytotoxic acitivity. All strains that were able to absorb antihuman cytotoxic activity from ASP 223 shared the specificity H-2.8. Thus, the H-2.37 specificity seems to be responsible for strong and the H-2.8 specificity for weak absorbing capacity. The absorbing capacity of the H-2d haplotype was localized in the H-2.K end. Mouse lymph node cells have a 10- to 20-fold higher absorbing capacity for the antihuman activity than thymus cells. It was shown that H-2.K end public specificities predominantly expressed on lymph node cells are responsible for the generation of antihuman (anti-HLA) cytotoxic activity in anti-H-2 sera.
使用已知能与人细胞产生强烈细胞毒性反应的同基因抗H2f小鼠血清对人外周淋巴细胞进行吸收实验及后续重新检测,该反应与人HLA - A2抗原的存在相关(小鼠血清ASP 223,供体品系B10.M (H - 2f),受体为(B10×A.SW)F1 (H - 2b/H - 2s)杂种;血清中存在的抗体为抗H - 2.9、8、37)。根据用于吸收的A2阴性细胞剂量,该血清可在操作上对HLA - A2具有单特异性。用不同小鼠品系的淋巴结细胞进行的吸收实验表明,H - 2f.p.w7单倍型具有用约15×10⁶个细胞完全吸收抗人活性的能力。因此,抗人活性并非归因于血清中抗H - 2.9私有特异性的存在。H - 2d.k.r单倍型的吸收能力较弱,因为需要500×10⁶个淋巴结细胞才能吸收70%的抗人细胞毒性活性。所有能够从ASP 223中吸收抗人细胞毒性活性的品系都具有H - 2.8特异性。因此,H - 2.37特异性似乎与强吸收能力有关,而H - 2.8特异性与弱吸收能力有关。H - 2d单倍型的吸收能力定位于H - 2.K末端。小鼠淋巴结细胞对抗人活性的吸收能力比胸腺细胞高10至20倍。结果表明,主要在淋巴结细胞上表达的H - 2.K末端公共特异性是抗H - 2血清中抗人(抗HLA)细胞毒性活性产生的原因。